Streamlining Publications Development with Real-Time Co-Authoring

June 12, 2019Case Study

A multibillion-dollar global pharmaceutical firm became frustrated with the time-consuming and labor-intensive publication process and wanted to improve it. To achieve its primary goals of finalizing a manuscript more quickly and improving the overall experience for authors, the company decided to use a co-authoring platform to shorten timelines, keep proprietary information secure, and give authors more flexibility to make more thoughtful and thorough contributions.

In this success story, learn how a leading drug company leveraged co-authoring technology to simplify and expedite the manuscript development process.